Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 2
2000 3
2001 1
2002 2
2003 3
2004 4
2005 5
2006 4
2007 3
2008 3
2009 2
2011 1
2012 2
2013 3
2014 1
2015 1
2016 3
2017 1
2018 3
2019 5
2020 7
2021 5
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

69 results
Results by year
Filters applied: . Clear all
Page 1
Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline.
Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, Gaga M, Kellermeyer L, Khurana S, Knight S, McDonald VM, Morgan RL, Ortega VE, Rigau D, Subbarao P, Tonia T, Adcock IM, Bleecker ER, Brightling C, Boulet LP, Cabana M, Castro M, Chanez P, Custovic A, Djukanovic R, Frey U, Frankemölle B, Gibson P, Hamerlijnck D, Jarjour N, Konno S, Shen H, Vitary C, Bush A. Holguin F, et al. Among authors: diver s. Eur Respir J. 2020 Jan 2;55(1):1900588. doi: 10.1183/13993003.00588-2019. Print 2020 Jan. Eur Respir J. 2020. PMID: 31558662 Free article.
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial.
Diver S, Khalfaoui L, Emson C, Wenzel SE, Menzies-Gow A, Wechsler ME, Johnston J, Molfino N, Parnes JR, Megally A, Colice G, Brightling CE; CASCADE study investigators. Diver S, et al. Lancet Respir Med. 2021 Nov;9(11):1299-1312. doi: 10.1016/S2213-2600(21)00226-5. Epub 2021 Jul 10. Lancet Respir Med. 2021. PMID: 34256031 Clinical Trial.
Cough and Eosinophilia.
Diver S, Russell RJ, Brightling CE. Diver S, et al. J Allergy Clin Immunol Pract. 2019 Jul-Aug;7(6):1740-1747. doi: 10.1016/j.jaip.2019.04.048. J Allergy Clin Immunol Pract. 2019. PMID: 31279462 Review.
Letter from the UK.
Diver S, Brightling C, Ohri C. Diver S, et al. Respirology. 2020 Dec;25(12):1323-1324. doi: 10.1111/resp.13957. Epub 2020 Oct 19. Respirology. 2020. PMID: 33078495 Free article. No abstract available.
The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.
McDowell PJ, Diver S, Yang F, Borg C, Busby J, Brown V, Shrimanker R, Cox C, Brightling CE, Chaudhuri R, Pavord ID, Heaney LG; Medical Research Council: Refractory Asthma Stratification Programme (RASP-UK Consortium). McDowell PJ, et al. Among authors: diver s. Lancet Respir Med. 2021 Oct;9(10):1174-1184. doi: 10.1016/S2213-2600(21)00004-7. Epub 2021 May 7. Lancet Respir Med. 2021. PMID: 33971168
New and emerging drug treatments for severe asthma.
Diver S, Russell RJ, Brightling CE. Diver S, et al. Clin Exp Allergy. 2018 Mar;48(3):241-252. doi: 10.1111/cea.13086. Epub 2018 Feb 13. Clin Exp Allergy. 2018. PMID: 29315966 Review.
Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD.
Winslow S, Odqvist L, Diver S, Riise R, Abdillahi S, Wingren C, Lindmark H, Wellner A, Lundin S, Yrlid L, Ax E, Djukanovic R, Sridhar S, Higham A, Singh D, Southworth T, Brightling CE, Olsson HK, Jevnikar Z. Winslow S, et al. Among authors: diver s. Eur Respir J. 2021 Oct 14;58(4):2003312. doi: 10.1183/13993003.03312-2020. Print 2021 Oct. Eur Respir J. 2021. PMID: 33766947
Big asthma data: getting bigger and more beautiful?
Diver S, Brightling CE. Diver S, et al. Thorax. 2018 Apr;73(4):311-312. doi: 10.1136/thoraxjnl-2017-211148. Epub 2017 Dec 29. Thorax. 2018. PMID: 29288213 No abstract available.
Enyne metathesis (enyne bond reorganization).
Diver ST, Giessert AJ. Diver ST, et al. Chem Rev. 2004 Mar;104(3):1317-82. doi: 10.1021/cr020009e. Chem Rev. 2004. PMID: 15008625 Review. No abstract available.
69 results